CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma

Published:2013-04-25 Issue:1 Volume:162 Page:87-92
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mitrovic Zdravko,Iqbal Javeed¹,Fu Kai¹,Smith Lynette M.²,Bast Martin³,Greiner Timothy C.¹,Aoun Patricia¹,Armitage James O.³,Vose Julie M.³,Weisenburger Dennis D.¹,Chan Wing C.¹

Affiliation:

1. Department of Pathology and Microbiology; University of Nebraska Medical Center; Omaha; NE; USA

2. Department of Biostatistics; University of Nebraska Medical Center; Omaha; NE; USA

3. Division of Hematology and Oncology; University of Nebraska Medical Center; Omaha; NE; USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12356/fullpdf

Reference22 articles.

1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000

2. Disregulation of leukosialin (CD43, Ly48, sialophorin) expression in the B-cell lineage of transgenic mice increases splenic B-cell number and survival;Dragone;Proceedings of the National Academy of Sciences of the United States of America,1995

3. Detection of immunophenotypic abnormalities in paraffin-embedded B-lineage non-Hodgkin's lymphomas;Gelb;American Journal of Clinical Pathology,1994

4. Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy;Gutiérrez-García;Blood,2011

5. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray;Hans;Blood,2004

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UMG1/CD3ε‐bispecific T‐cell engager redirects T‐cell cytotoxicity against diffuse large B‐cell lymphoma;British Journal of Haematology;2023-11-14

2. Identification of novel targets for immunotherapies in subsets of patients with diffuse large B‐cell lymphoma (DLBCL);British Journal of Haematology;2023-11-14

3. Identification and validation of hub genes in CD5-positive diffuse large B-cell lymphoma;Experimental Biology and Medicine;2023-02-27

4. CD43 is an adverse prognostic factor in newly diagnosed multiple myeloma;Leukemia & Lymphoma;2022-07-12

5. Independent diagnostic utility of CD20, CD200, CD43 and CD45 in chronic lymphocytic leukaemia;Leukemia & Lymphoma;2021-10-22